On May 11, 2023 Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
On March 7, 2023 Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults
On December 1, 2022 Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later
On November 9, 2022 Vaccine Development: From Concept to Clinic, Chapter 10: Vaccine Adjuvants: Mechanisms of Action
On November 8, 2022 Lyophilization process engineering and thermostability of ID93 + GLA-SE, a single-vial adjuvanted subunit tuberculosis vaccine candidate for use in clinical studies